| Mr George Mcmickle, MD | |
|
653 N Town Center Dr, Ste #318, Las Vegas, NV 89144-0514 | |
| (702) 215-6950 | |
| (702) 215-3377 |
| Full Name | Mr George Mcmickle |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 29 Years |
| Location | 653 N Town Center Dr, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912935065 | NPI | - | NPPES |
| 2018497 | Medicaid | NV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | NV9367 (Nevada) | Primary |
| Entity Name | George R Mcmickle Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972931426 PECOS PAC ID: 5193950392 Enrollment ID: O20131024000000 |
News Archive
The chief justice treads a very narrow path to find the health law constitutional and helps to redefine the public's view of the court.
SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced the acceptance of three abstracts from the SuperGen PIM kinase inhibitor program. Poster presentations by SuperGen and collaborators will occur on April 3 and 5, 2011 at the American Association for Cancer Research 102nd Annual Meeting in Orlando, Florida.
Hybridon today announced it had entered into research collaboration and license agreements with Novartis for the discovery, optimization, development and commercialization of Toll-like receptor 9 (TLR9) drug candidates targeting asthma and allergy based on Hybridon's proprietary immune modulatory oligonucleotide (IMO) technology platform.
Waters Corporation is showcasing its portfolio of MassTrak solutions at the American Association of Clinical Chemistry annual meeting and Clinical Lab Expo July 25 - 29, 2010 in Anaheim in exhibit booth #4447. Waters portfolio of MassTrak Solutions for the clinical laboratory combines the power of separations science, tandem mass spectrometry, specialized chemistries, software, and support services in ways designed to optimize laboratory processes.
When San Francisco voters overwhelmingly approved a ballot measure banning the sale of flavored tobacco products in 2018, public health advocates celebrated. After all, tobacco use poses a significant threat to public health and health equity, and flavors are particularly attractive to youth.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr George Mcmickle, MD 653 N Town Center Dr, Suite 318, Las Vegas, NV 89144-0514 Ph: (702) 215-6950 | Mr George Mcmickle, MD 653 N Town Center Dr, Ste #318, Las Vegas, NV 89144-0514 Ph: (702) 215-6950 |
News Archive
The chief justice treads a very narrow path to find the health law constitutional and helps to redefine the public's view of the court.
SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced the acceptance of three abstracts from the SuperGen PIM kinase inhibitor program. Poster presentations by SuperGen and collaborators will occur on April 3 and 5, 2011 at the American Association for Cancer Research 102nd Annual Meeting in Orlando, Florida.
Hybridon today announced it had entered into research collaboration and license agreements with Novartis for the discovery, optimization, development and commercialization of Toll-like receptor 9 (TLR9) drug candidates targeting asthma and allergy based on Hybridon's proprietary immune modulatory oligonucleotide (IMO) technology platform.
Waters Corporation is showcasing its portfolio of MassTrak solutions at the American Association of Clinical Chemistry annual meeting and Clinical Lab Expo July 25 - 29, 2010 in Anaheim in exhibit booth #4447. Waters portfolio of MassTrak Solutions for the clinical laboratory combines the power of separations science, tandem mass spectrometry, specialized chemistries, software, and support services in ways designed to optimize laboratory processes.
When San Francisco voters overwhelmingly approved a ballot measure banning the sale of flavored tobacco products in 2018, public health advocates celebrated. After all, tobacco use poses a significant threat to public health and health equity, and flavors are particularly attractive to youth.
› Verified 9 days ago
Dr. Jason Craig Wickens, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 653 N Town Center Dr Ste 518, Las Vegas, NV 89144 Phone: 702-369-0200 Fax: 702-243-8383 | |
Dr. Surjeet Singh, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2020 Wellness Way Ste 401, Las Vegas, NV 89106 Phone: 702-896-6043 Fax: 702-896-9591 | |
Peter Lloyd Hildebrand, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 2020 Wellness Way Ste 402, Las Vegas, NV 89106 Phone: 702-485-5000 Fax: 702-485-5005 | |
Dr. Brett D Brimhall, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6850 N Durango Dr, 110, Las Vegas, NV 89149 Phone: 702-263-2020 Fax: 702-396-0287 | |
Helga F Pizio, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2020 Wellness Way Ste 402, Las Vegas, NV 89106 Phone: 702-485-5000 Fax: 702-485-5001 | |
Grace S Shin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6028 S Fort Apache Rd Ste 101, Las Vegas, NV 89148 Phone: 702-896-2020 Fax: 702-896-2025 | |
Dr. Jeffrey L. Hart, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5871 W. Craig Rd., Las Vegas, NV 89130 Phone: 702-724-2020 Fax: 702-724-2800 |